INCA035784 clinical trials

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

This study is looking into a new medicine, INCA035784, for people with blood cancers called myeloproliferative neoplasms (MPNs). The main goal is to check how safe it is and if people can tolerate it well, meaning how their bodies react to the treatment.